Next Article in Journal
EBV Positive Diffuse Large B Cell Lymphoma and Chronic Lymphocytic Leukemia Patients Exhibit Increased Anti-dUTPase Antibodies
Next Article in Special Issue
A New Strategy to Control and Eradicate “Undruggable” Oncogenic K-RAS-Driven Pancreatic Cancer: Molecular Insights and Core Principles Learned from Developmental and Evolutionary Biology
Previous Article in Journal
Responses to the Selective Bruton’s Tyrosine Kinase (BTK) Inhibitor Tirabrutinib (ONO/GS-4059) in Diffuse Large B-cell Lymphoma Cell Lines
Previous Article in Special Issue
Role of Gene Therapy in Pancreatic Cancer—A Review
 
 
Review

Article Versions Notes

Cancers 2018, 10(5), 128; https://doi.org/10.3390/cancers10050128
Action Date Notes Link
article xml file uploaded 28 April 2018 09:43 CEST Original file -
article xml uploaded. 28 April 2018 09:43 CEST Update https://www.mdpi.com/2072-6694/10/5/128/xml
article pdf uploaded. 28 April 2018 09:43 CEST Version of Record https://www.mdpi.com/2072-6694/10/5/128/pdf
article html file updated 28 April 2018 09:44 CEST Original file -
article html file updated 30 May 2018 17:50 CEST Update -
article html file updated 29 March 2019 20:12 CET Update -
article html file updated 17 April 2019 00:25 CEST Update -
article html file updated 30 April 2019 23:47 CEST Update -
article html file updated 3 October 2019 02:07 CEST Update -
article html file updated 9 February 2020 15:43 CET Update -
article html file updated 16 July 2022 11:06 CEST Update https://www.mdpi.com/2072-6694/10/5/128/html
Back to TopTop